Unknown

Dataset Information

0

Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies.

ABSTRACT: The present work is an investigation to test hydroxychloroquine as an inhibitor for the COVID-19 main protease. Molecular docking studies revealed a high docking score and interaction energies and decent level of docking within the cavity in protease moiety. Molecular dynamics simulations also lead to the evaluation of conformational energies, average H-bonding distance, RMSD plots etc. Large RMSD fluctuations for the first 2 ns seem to provide the conformational and rotational changes associated with the drug molecule when it comes into the vicinity on the protease matrix. Snapshots of structural changes with respect to time vividly indicates that drug molecule has a profound impact on the binding sites as well as overall geometry of the protease moiety. On the whole, hydroxyxhloroquine confers good inhibitory response to COVID-19 main protease. We hope the present study should help workers in the field to develop potential vaccines and therapeutics against the novel coronavirus.

SUBMITTER: Baildya N 

PROVIDER: S-EPMC7266611 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies.

Baildya Nabajyoti N   Ghosh Narendra Nath NN   Chattopadhyay Asoke P AP  

Journal of molecular structure 20200602

The present work is an investigation to test hydroxychloroquine as an inhibitor for the COVID-19 main protease. Molecular docking studies revealed a high docking score and interaction energies and decent level of docking within the cavity in protease moiety. Molecular dynamics simulations also lead to the evaluation of conformational energies, average H-bonding distance, RMSD plots etc. Large RMSD fluctuations for the first 2 ns seem to provide the conformational and rotational changes associate  ...[more]

Similar Datasets

Unknown Inhibitory effect of compounds extracted from <i>Monochoria hastata</i> (L.) Solms on SARS-CoV-2 main protease: An insight from molecular docking and MD-simulation studies.
| S-EPMC8846558 | biostudies-literature
Unknown Comparative MD Study of Inhibitory Activity of Opaganib and Adamantane-Isothiourea Derivatives toward COVID-19 Main Protease M<sup>pro</sup>.
| S-EPMC8662094 | biostudies-literature
Unknown Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease.
| S-EPMC7873971 | biostudies-literature
Unknown Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies.
| S-EPMC8051003 | biostudies-literature
Unknown Finding potential inhibitors for Main protease (Mpro) of SARS-CoV-2 through virtual screening and MD simulation studies.
| S-EPMC10663854 | biostudies-literature
Unknown Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors.
| S-EPMC7647411 | biostudies-literature
Unknown Inhibitory activity of FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, remdesivir, and hydroxychloroquine on COVID-19 main protease and human ACE2 receptor: A comparative in silico approach.
| S-EPMC8455240 | biostudies-literature
Unknown Structural dynamics of COVID-19 main protease.
| S-EPMC7480992 | biostudies-literature
Clinical Main Postoperative Complications After COVID-19
| 5792 | ecrin-mdr-crc
Unknown A dynamic simulation study of FDA drug from zinc database against COVID-19 main protease receptor.
| S-EPMC7544932 | biostudies-literature